MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Language Impairment in Isolated Rapid Eye Movement Sleep Behavior Disorder and de-novo Parkinson’s disease

    M. šubert, M. šimek, M. Novotný, T. Tykalová, O. Bezdíček, E. Růžička, K. šonka, P. Dušek, J. Rusz (Prague 6, Czech Republic)

    Objective: This study aimed to examine whether the language impairment is presented in isolated rapid eye movement sleep behavior disorder (iRBD) and early-stage Parkinson’s disease…
  • 2022 International Congress

    Investigating inflammatory mechanisms in iPSC-derived LRRK2 microglia

    K. Badanjak, P. Mulica, P. Seibler, M. Ali, C. Venegas, S. Pereira, C. Klein, P. Antony, E. Glaab, A. Grünewald (Esch-Sur-Alzette, Luxembourg)

    Objective: To characterize microglial function and inflammatory mechanisms in LRRK2-associated Parkinson’s disease (PD). Background: PD is a neurodegenerative disease affecting primarily dopaminergic neurons of the…
  • 2022 International Congress

    EFFECTS OF OPICAPONE IN PARKINSON DISEASE AS ASSESSED BY KINEMATIC TECHNIQUES

    D. Colella, A. de Biase, A. Cannavacciuolo, L. Angelini, A. Guerra, G. Paparella, A. Berardelli, G. Fabbrini, M. Bologna (Rome, Italy)

    Objective: We aimed to objectively investigate the effects of Opicapone on bradykinesia in Parkinson's Disease (PD) by kinematic analysis. Background: By increasing L-dopa bioavailability, catechol-O-methyl…
  • 2022 International Congress

    A second level neuropsychological battery for Parkinson’s Disease. Normative data from the Italian population.

    T. Gandolfi, G. Arcara, S. Cuoco, C. Siri, L. Weis, E. Reali, M. Garon, F. Pistonesi, V. Cianci, E. Fiorenzato, G. Santangelo, G. Pezzoli, P. Barone, A. Antonini, R. Biundo (Padova, Italy)

    Objective: The main purpose of this work is to propose modern Italian co-normed data for a battery of ten widely used neuropsychological tests for Parkinsons’…
  • 2022 International Congress

    NODDI- based maps as potential marker for Parkinson’s Disease.

    AP. Prabhu, S. Bhardwaj, A. Indoria, M. Gothwal, R. Yadav, PK. Pal, J. Saini (Bengaluru, India)

    Objective: To assess the predictive power of Diffusion Kurtosis Imaging (DKI) parameters obtained from Neurite orientation dispersion and density imaging tool (NODDI) to differentiate between…
  • 2022 International Congress

    Are Subjective Cognitive Complaints a predictor of future cognitive decline in Parkinson´s Disease? – A longitudinal study

    M. Magriço, B. Meira, M. Fernandes, M. Saraiva, M. Salavisa, C. Borbinha, J. Maro, F. Ladeira, R. Barbosa, P. Bugalho (Lisboa, Portugal)

    Objective: We aim to determine whether subjective cognitive complaints (SCC) may predict the development of cognitive impairment in Parkinson´s Disease (PD) Background: Subjective cognitive complaints…
  • 2022 International Congress

    Repetitive transcranial magnetic stimulation for hypokinetic dysarthria in PD enhances white matter integrity in the auditory-motor loop tract

    I. Rektorova, L. Brabenec, M. Kostalova, A. Sejnoha-Minsterova (Brno, Czech Republic)

    Objective: To test effects of repetitive transcranial magnetic stimulation (rTMS) for hypokinetic dysarthria in PD on white matter integrity changes of the left anterior arcuate…
  • 2022 International Congress

    Machine Learning and Instrumented Gait Analysis to Classify Subthalamic DBS States in Parkinson’s Disease

    J. Watts, A. Khojandi, R. Ramdhani (Knoxville, USA)

    Objective: This study investigates whether gait features derived from an instrumented walk can predict specific treatment conditions (stimulation frequency and medication status)  in a cohort…
  • 2022 International Congress

    Longitudinal assessment of quality of life in early Parkinson’s disease: 5-year follow up study

    I. Stankovic, T. Pekmezovic, V. Markovic, N. Dragasevic, I. Petrovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: To determine changes in HR-QoL in early PD patients during a 5-year follow up period. Background: There is limited evidence on longitudinal changes in…
  • 2022 International Congress

    Factors that negatively impact the sexual function of women living with Parkinson’s disease

    K. Nobrega, R. Gonçalves, B. Silva, B. Souza, M. Piemonte (Macapa, Brazil)

    Objective: To investigate the impact of motor and non-motor alterations and couple adjustment on sexual function in women living with PD in Brazil. Background: Among…
  • « Previous Page
  • 1
  • …
  • 327
  • 328
  • 329
  • 330
  • 331
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley